Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Pfizer describes a new series of CRF antagonists

Nov. 1, 1996

Japanese researchers disclose glutamate antagonists

Nov. 1, 1996

Alzheimer's disease linked to immunoinflammatory response

Nov. 1, 1996

Eisai files for approval of Aricept

Nov. 1, 1996

Meiji Seika discloses compounds that enhance axonal regeneration

Nov. 1, 1996

Merck NK1 antagonist shows antiemetic activity in ferrets

Nov. 1, 1996

N-type calcium channel blockers from Sankyo

Nov. 1, 1996

Pfizer 5-HT reuptake inhibitor approved in U.S. for new indication

Nov. 1, 1996

Anxiolytic activity of phytomedicine established in patients

Nov. 1, 1996

Melatonergic agents reported by BMS

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...